MoonLake Immunotherapeutics
Pharmaceutical company · Zug, Switzerland · Nasdaq: MLTX
MoonLake Immunotherapeutics is a pharmaceutical company headquartered in Zug, Switzerland. Its shares trade on Nasdaq under the ticker MLTX.
Profile compiled from public records. Is this your company? Request a correction or update
MoonLake Immunotherapeutics at a glance
Typepharmaceutical company
HeadquartersZug, Switzerland
Stock listingNasdaq: MLTX
SEC industryPharmaceutical Preparations
SEC CIK1821586
Frequently asked questions about MoonLake Immunotherapeutics
Where is MoonLake Immunotherapeutics headquartered?
MoonLake Immunotherapeutics is headquartered in Zug, Switzerland.
What does MoonLake Immunotherapeutics do?
MoonLake Immunotherapeutics is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is MoonLake Immunotherapeutics a public company?
Yes. MoonLake Immunotherapeutics trades on Nasdaq under the ticker MLTX.
Similar companies
- Oculis Holding AGZug, Switzerland
- MindMaze Therapeutics Holding SAGeneva, Switzerland
- Novartis AgBasel, Basel-City, Switzerland
- BeOne Medicines Ltd.Basel, Basel-City, Switzerland
- Addex Therapeutics Ltd.Geneva, Switzerland
- NewcelX Ltd.Zürich, Zurich, Switzerland
- ADC Therapeutics SAEpalinges, Vaud, Switzerland
- AC Immune SALausanne, Vaud, Switzerland
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences